The primary treatment for SCID is a hematopoietic stem cell transplant (HSCT), which can restore a functional immune system. The success of HSCT is highest when performed early, ideally before the infant reaches three months of age. Other treatment options include enzyme replacement therapy for ADA deficiency and gene therapy, which is an emerging treatment modality that aims to correct the underlying genetic defect.